2020-2027 Analysis and Review Chromosome Enumeration Probes Market

Chromosome Enumeration Probes Market

Chromosome Enumeration Probes Market by Clinical Application (Oncology, Autoimmune Diseases and Others) by Type (Single Color Probe, Dual Color Probe and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 – 2027

02-06-2020 REP-HC-5104 40 Tables 110 pages Format

The chromosome enumeration probes market was valued at USD 216.6 Mn by 2019. The rising prevalence of metastatic cancer worldwide primarily drives the market growth. Increasing research and development for novel drug development for the treatment of autoimmune diseases will further accentuate market growth.

Chromosome Enumeration Probes Market

Molecular diagnostics has undergone technological advancement in the last decade majorly focusing on the manufacturing of chromosome enumeration probes to develop the analysis of DNA and RNA molecules present in the clinical samples under investigation. It serves the double purpose of detecting and monitoring the disease progression and aids in customizing the therapy most suitable for ailing patients. Increasing demand for personalized medication provides a positive impetus to the chromosomes enumeration probes market growth. These probes can be either labeled by radioisotopes or non-radioisotopes such as digoxigenin, biotin, etc. to enhance the biological assays employing chromosomes enumeration probes.

The major segments related to the chromosome enumeration probes market are: 

By Clinical Application (2017–2027; US$ Mn)

Oncology

Autoimmune Diseases

Others

By Type (2017–2027; US$ Mn)

Single Color Probe

Dual Color Probe

Others

Geography Segment (2017–2027; US$ Mn)

North America

U.S.
Canada

Europe

United Kingdom
Germany
Russia
France
Italy
Spain
Ukraine
Rest of Europe

Asia Pacific

China
Japan
Rest of Asia Pacific

Latin America (LATAM)

Brazil
Mexico
Rest of Latin America

Middle East and Africa (MEA)

GCC
Rest of MEA 

Justification for study?

  • The intention of the study is to give a comprehensive outlook of the global chromosome enumeration probes market
  • The overall segmentation of the chromosome enumeration probes market, by clinical application, type, and geography is minutely studied. Oncology and dual-color probes are dominating the clinical application and type segments respectively
  • Rising prevalence of metastatic cancer cases worldwide
  • Increasing demand for biological molecules and targeted drug therapy for autoimmune diseases across life sciences industries.

Report gist?

  • The study of the global chromosome enumeration probes market includes qualitative analysis of factors such as drivers, restraints, and opportunities
  • The report covers the qualitative and quantitative analysis of the overall market segmented on the basis of clinical application and type and categorization of the same at the geography level
  • This research report presents the analysis of each segment from 2017 to 2027 in which 2019 is considered as the base year. The compounded annual growth rate is calculated for the respective segments from 2020 to 2027

The study includes the profiles of major market players with a significant global and regional presence along with top company positioning. 

Significant customers?

  • This study is suitable for industry participants and stakeholders in the biopharmaceutical manufacturers actively engaged in the production and marketing of chromosome enumeration probes due to the  rising prevalence of metastatic cancer cases worldwide
  • The report will benefit formulation researchers engaged in the development of novel therapy for the treatment of autoimmune diseases
  • Managers with financial institutions looking to publish recent and forecasted statistics pertaining to chromosome enumeration probes market
  • Financial institutions, venture capitalist, analysts, investors, government organizations, policymakers, regulatory authorities, researchers, looking for insights into the market to determine future strategies 

Segment Analysis

Oncology is presently leading the clinical application segment for chromosomes enumeration probes market. As per the statistics provided by the World Health Organization (WHO), cancer is the 2nd leading cause of death worldwide, responsible for the death of 9.6 million people in 2018 throughout the globe. Rising public health awareness has resulted in early screening and treatment for metastatic cancer, there is a tremendous requirement for biologics and targeted drug therapy for the treatment of cancer. Autoimmune diseases are anticipated to register rampant market growth during the forecast period on account of its growing incidence and increasing research and development activities in the life sciences segment for novel drug development for its treatment.

In the current scenario, double color probes are dominating the types segment for chromosomes enumeration probes market. It is widely employed for its ability to enumerate human chromosomes in the interphase cells and also as an adjunct to the standard karyotyping in the metaphases. Dual-phase colors are vital in achieving sharp bright signals specific foe each individual chromosomes. Multicolor probes will be witnessing impressive market growth in the near future on account of its ability to increase the target volume in the real-time PCR detection in a single reaction.

North America is the supreme leader in the geography segment for the chromosome enumeration probes market. The rising prevalence of metastatic cancer primarily drives market growth in the region. According to the latest statistics provided by the American Cancer Society (ACS) in 2019, approximately 606,520 deaths associated with cancer have been recorded in the United States. Furthermore, the domicile of major players such as Abbott Laboratories, Empire Genomics, LLC., Cytocell, etc. further accentuates the market growth in the region. Europe is the second-largest regional segment in the chromosomes enumeration probes market. The growing incidence of autoimmune diseases determines market growth in the region. According to the latest research citings provided by the World Health Organization (WHO), approximately, 3 million people across Europe are suffering from inflammatory bowel disease. The Asia Pacific is anticipated to be the fastest-growing regional segment for chromosome enumeration probes market. Rising prevalence of chronic diseases and increasing funds provided by the government healthcare agencies to revamp the research and development activities in the life sciences segment will drive the market growth in the region.

Select License Type

$4,600
$6,600
$13,200

Safe and Secure SSL Encrypted

Have a Question?

We will help you find what you are looking for.

Call 1-518-730-1560

Contact sales

How can we help you?

Get in touch with us or find an office closest to you.